Health
PET/CT insights predict immunotherapy response in patients with advanced lung cancer – Health Imaging
Checkpoint inhibitors target the PD-L1/PD1 signaling pathway and are commonly used to treat those with NSCLC. While this therapy can be highly effective, it only works for nearly 50% of patients.
In order to avoid treating those who likely wont respond,…
Continue Reading
-
General13 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News23 hours agoRainbow Beach surfer’s untold 7/7 story
-
Noosa News13 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
Business20 hours agoInvested $10,000 in Westpac shares 2 years ago? Guess how much you’ve already banked!